Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.57 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.57 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.57 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | WNT3A | P56704 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6799294 | 0.87 | KMT2A (0.56) | KMT2AMEN1SLC6A2SLC6A3CHRNB2 | |
| SCHEMBL6491755 | 0.84 | KMT2A (0.50) | KMT2AMEN1SLC6A2SLC6A3RAB9A | |
| SCHEMBL6788071 | 0.82 | KDM4E (0.51) | KMT2AMEN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL6913405 | 0.82 | MEN1 (0.59) | KMT2AMEN1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6795709 | 0.81 | MEN1 (0.59) | KMT2AMEN1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6795782 | 0.81 | FFAR1 (0.67) | KMT2AMEN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL6645079 | 0.80 | KMT2A (0.51) | KMT2AMEN1SLC6A2SLC6A3RAB9A | |
| SCHEMBL6793810 | 0.79 | KDR (0.52) | KMT2AMEN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL6795340 | 0.78 | RAB9A (0.53) | KMT2AMEN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL6795020 | 0.77 | CHRNB2 (0.52) | CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | KMT2A 2457/4885MEN1 2426/4885SLC6A2 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.